CoChat

Low-dose quercetin positively regulates mouse healthspan

Open access
Geng, Lingling, Liu, Zunpeng, Wang, Si, Sun, Shuhui, Ma, Shuai, Liu, Xiaoqian, Chan, Piu, Sun, Liang, Song, Moshi, Zhang, Weiqi, Liu, Guang-Hui, Qu, Jing · 2019 · Protein & Cell
Cited by 58

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Aging is the leading risk factor for many chronic diseases, accounting for almost 60% of all deaths worldwide. How to achieve healthy aging, alleviate aging-related diseases, and extend healthspan has become a main topic of biomedical research (He et al., 2019). Geroprotective compounds, such as metformin and rapamycin, have been shown to improve both healthspan and lifespan in mice (Martin-Montalvo et al., 2013; Bitto et al., 2016), whereas nicotinamide partially improves healthspan in mice (Mitchell et al., 2018). In addition, senolytics, compounds that eliminate senescent cells, have been proven to improve physical function and increase lifespan in mice (Xu et al., 2018). Although none have proven to be clinically reliable in delaying aging or treating frailty in humans, these compounds have already provoked enthusiasm for identifying a potential “elixir”. Therefore, the exploration of more geroprotective compounds, especially natural active compounds, holds great potential for the development of geriatric medicines. Quercetin (Que) is a natural bioflavonoid found in fruits and vegetables such as apples and onions. Que (50 mg/kg) in combination with dasatinib (5 mg/kg) (abbreviated as D + Q) has been shown to effectively eliminate senescent cells via induction of apoptosis, thus alleviating senescence-related phenotypes and improving physical function and lifespan in mice (Zhu et al., 2015; Xu et al., 2018). In addition, Que (10 mg/kg) in combination with dasatinib (5 mg/kg) has been reported to reduce hepatic steatosis (Ogrodnik et al., 2017). In each of these in vivo studies, however, Que was used at high doses ranging from 10 to 50 mg/kg body weight, which raises concerns about dose-dependent side effects such as headaches and limb tingling (Shoskes et al., 1999). As a selective tyrosine kinase receptor inhibitor, dasatinib is associated with warnings and precautions including pulmonary arterial hypertension and low blood cell counts. Therefore, high-dose Que and extra side effects of dasatinib would hamper potential clinical applications of Que in geriatric medicines. Through natural products screening using Werner syndrome (WS) human mesenchymal stem cells (hMSCs), we recently identified Que as a geroprotective agent that counteracts accelerated and natural aging of hMSCs at a concentration of as low as 100 nmol/L, which is 100 times lower than the concentration of Que (10 μmol/L) previously used in combination with dasatinib as senolytic drugs to eliminate senescent cells in human umbilical vein cells (HUVECs) (Zhu et al., 2015; Geng et al., 2018). To explore the geroprotective effect of low-dose Que monotherapy in rodents, we evaluated the in vivo effect of long-term low-dose Que administration under physiologicalaging condition. Que was given to 14-month-old C57BL/6J male mice by weekly oral gavage at a concentration of 0.125 mg/kg body weight, which is 80–400 times lower than that of the previously tested D + Q (10–50 mg/kg body weight) regimens (Fig. 1A), with vehicle (10% PEG400 in PBS)treated mice as controls (Zhu et al., 2015; Xu et al., 2018). After eight months of treatment, Que-treated mice showed decreased hair loss with normal food intake, body weight, blood glucose and bone mineral density (Figs. 1B and S1A– D). Compared to vehicle-treated mice, mice subjected to Que treatment showed markedly improved exercise endurance in the RotaRod and treadmill tests, but normal grip strength by grip strength meter assay (Figs. 1C, 1D, and S1E–G). Accordingly, the cardiac function of these mice was examined by Doppler tissue imaging. Although ejection fraction (EF) and fractional shortening (FS) were unaffected, a higher frequency of the mitral ratio of peak early to late diastolic filling velocity (E/A) within the normal range was observed in Que-treated mice than in the age-matched controls (Figs. 1E and S1H). However, the lifespan was not prolonged by low-dose Que treatment observed up to the age of 31 months (Fig. S1I). Taken together, these data indicate that long-term low-dose Que administration alone sufficiently improves multiple aspects of healthspan, but not lifespan, in mice. To investigate how Que improved healthspan in mice, we collected 11 different kinds of tissues from 10-week young male mice (Y-Ctrl) and vehicle (O-Veh)and low-dose Quetreated 22-month old male mice (O-Que). No significant difference was observed in organ weights between O-Veh and O-Que (Fig. S2A). Given that exercise endurance and diastolic function were improved by Que, we particularly examined the changes in skeletal muscles (SKM), white adipose tissues (WAT), brown adipose tissues (BAT) and hearts. Upon Que treatment, the arrangement of muscle fibers became more regular and compact with less fibrosis

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13238-019-0646-8

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 58

Metadata

Authors
Geng, L., Liu, Z., Wang, S., Sun, S., Ma, S., Liu, X., Chan, P., Sun, L., Song, M., Zhang, W., Liu, G.-H., & Qu, J.
Venue
Protein & Cell
Published
2019-07-19
Volume
10
Issue
10
Pages
770-775
ISSN
  • 1674-800X (ISSN-L)
  • 1674-8018
OpenAlex
W2964032281
Cited by
58
References
10
FWCI
1.80
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-dose quercetin positively regulates mouse healthspan. https://app.cochat.ai/papers/10.1007/s13238-019-0646-8
The paper
Geng, L., Liu, Z., Wang, S., Sun, S., Ma, S., Liu, X., Chan, P., Sun, L., Song, M., Zhang, W., Liu, G.-H., & Qu, J. (2019). Low-dose quercetin positively regulates mouse healthspan. Protein & Cell. https://doi.org/10.1007/s13238-019-0646-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.